Molecular volume determines the activity of the halogenated alkane bromoform at wild-type and mutant GABA(A) receptors.
The GABA(A) receptor is an important target for a variety of general anesthetics, including halogenated ethers such as isoflurane and halogenated ethers such as chloroform. Bromoform is a halogenated alkane that exhibits anesthetic properties and has been shown by X-ray crystallography to bind to model anesthetic targets. In this study we report the ability of bromoform to potentiate GABA-induced current in recombinant GABA(A) receptors composed of alpha(1)beta(2)gamma(2s) subunits. Recent studies have shown that specific point mutations in the transmembrane (TM) region of the GABA(A) receptor alpha-subunit can selectively abolish the modulatory activity of specific general anesthetics, and that molecular volume is a key determinant of anesthetic activity. The action of bromoform was examined in a series of mutant receptors and compared with the activity profiles of three other volatile anesthetics. The pharmacological profile of bromoform at the mutant receptors used in this study was similar to that seen with halothane, and distinct from that observed for isoflurane and chloroform. The molecular volume of bromoform is closest to that of halothane, and therefore our data are consistent with the idea that molecular volume is an important determinant of inhaled anesthetic activity at the GABA(A) receptor.
Kash
Thomas L
TL
Graduate Program in Neuroscience, Weill Graduate School of Medical Sciences of Cornell University, New York, NY 10021, USA.
Jenkins
Andrew
A
Harrison
Neil L
NL
D018685:Anesthetics, Inhalation / Q000737:chemistry / Q000494:pharmacology*; D002478:Cells, Cultured; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D018076:DNA, Complementary / Q000096:biosynthesis / Q000235:genetics; D004594:Electrophysiology; D018756:GABA Antagonists / Q000494:pharmacology; D058788:GABA-B Receptor Antagonists; D006801:Humans; D008564:Membrane Potentials / Q000502:physiology; D008970:Molecular Weight; D018408:Patch-Clamp Techniques; D010852:Picrotoxin / Q000494:pharmacology; D017354:Point Mutation / Q000235:genetics / Q000502:physiology; D018080:Receptors, GABA-B / Q000235:genetics*; D011994:Recombinant Proteins; D022882:Trihalomethanes / Q000737:chemistry / Q000494:pharmacology*
D018685:Anesthetics, Inhalation; D018076:DNA, Complementary; D018756:GABA Antagonists; D058788:GABA-B Receptor Antagonists; D010852:Picrotoxin; D018080:Receptors, GABA-B; D011994:Recombinant Proteins; D022882:Trihalomethanes; C015044:bromoform